ProPhase Labs (PRPH) Cash & Equivalents (2010 - 2026)
ProPhase Labs' Cash & Equivalents was $20,000 in Q2 2026, down 88.2% from $169,000 a year earlier and down 35.5% from the prior quarter.
Powered by 
Analysis
ProPhase Labs (PRPH) Cash & Equivalents (2010 - 2026) Analysis & Trends
At the end of FY2025, Cash & Equivalents at ProPhase Labs came in at $90,000, down 86.7% from FY2024.
- Cash & Equivalents has now declined for three consecutive years, with a five-year compound annual growth rate of -57.9% (FY2020 to FY2025).
- In earlier years, Cash & Equivalents was $678,000 in FY2024 (-57.9%), $1.61 million in FY2023 (-82.3%), $9.11 million in FY2022 (+8.3%) and $8.41 million in FY2021 (+23.4%).
- The Q2 2026 figure marks the lowest quarterly Cash & Equivalents in data going back to Q2 2010.
- Compared with a year earlier, Cash & Equivalents has declined for 14 straight quarters, with an average decline of 66.0% over the last eight quarters.
- The best year-over-year quarter for Cash & Equivalents over five years was Q3 2022 (growth of 159.6%); the worst was Q3 2023 (a decline of 96.9%).
- Per Business Quant data, PRPH's Cash & Equivalents in the three quarters before Q2 2026 was $31,000 (Q1 2026), $90,000 (Q4 2025) and $405,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 20.42 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 4.89 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 976.00 Mn |
| 10 | ProPhase Labs | 155,925.56 | -390,074.44 | 226,000.00 | 20,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 20,000.00 |
| Mar 31, 2026 | 31,000.00 |
| Dec 31, 2025 | 90,000.00 |
| Sep 30, 2025 | 405,000.00 |
| Jun 30, 2025 | 169,000.00 |
| Mar 31, 2025 | 88,000.00 |
| Dec 31, 2024 | 678,000.00 |
| Sep 30, 2024 | 501,000.00 |
| Jun 30, 2024 | 1.78 Mn |
| Mar 31, 2024 | 1.18 Mn |
| Dec 31, 2023 | 1.61 Mn |
| Sep 30, 2023 | 702,000.00 |
| Jun 30, 2023 | 3.82 Mn |
| Mar 31, 2023 | 9.61 Mn |
| Dec 31, 2022 | 9.11 Mn |
| Sep 30, 2022 | 22.80 Mn |
| Jun 30, 2022 | 24.00 Mn |
| Mar 31, 2022 | 25.81 Mn |
| Dec 31, 2021 | 8.41 Mn |
| Sep 30, 2021 | 8.78 Mn |
API Access
ProPhase Labs Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=PRPH&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "PRPH", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=PRPH&period=max&api_key=YOUR_API_KEY");
const data = await res.json();